WeChat Mini Program
Old Version Features

Abstract PO2-20-03: VERITAC-3: A randomized phase 3 study, with a lead-in, of first-line vepdegestrant + palbociclib vs letrozole + palbociclib in estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer

Seth Wander,Erika Hamilton,Mario Campone,Michael Danso,Sara Hurvitz,Hiroji Iwata,Colombe Chappey,Derek Yang,Julia Perkins Smith,Yuan Liu, Yuanyuan Zhang,Sibyl Anderson,Michelino de Laurentiis

Cancer Research（2024）

Cited 0|Views16
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined